Mild Head Trauma (MHT) and Antiplatelet Therapy. Reply to Lorenzati et al. Comment on "Savioli et al. Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for Hemorrhagic Complications? Medicina 2021, 57, 357"

Medicina (Kaunas). 2021 Aug 27;57(9):889. doi: 10.3390/medicina57090889.

Abstract

We read your data with interest, and we truly appreciate the similar experience [...].

MeSH terms

  • Craniocerebral Trauma* / complications
  • Humans
  • Platelet Aggregation Inhibitors* / adverse effects
  • Risk Factors

Substances

  • Platelet Aggregation Inhibitors